UCSF Breakthrough: Protein Manipulation Reverses Memory Loss in Aging Mice

Researchers identify FTL1 protein as key driver of cognitive decline, offering potential new therapy

Apr. 12, 2026 at 10:55am by

Got story updates? Submit your updates here. ›

A highly structured abstract painting in soft, earthy tones, featuring sweeping geometric arcs, concentric circles, and precise botanical spirals, conceptually representing the complex interplay between the FTL1 protein, neural connections, and cognitive function in the aging brain.A breakthrough study at UCSF uncovers the pivotal role of the FTL1 protein in reversing age-related memory loss, offering new hope for combating cognitive decline.San Francisco Today

In a groundbreaking discovery, researchers at the University of California, San Francisco (UCSF) have found that lowering levels of the FTL1 protein can reverse age-related memory loss and cognitive decline in aging mice. The study, published in 2025, sheds light on the role of FTL1 in brain aging and opens up possibilities for developing targeted therapies to combat cognitive impairment.

Why it matters

The UCSF findings represent a significant advancement in the understanding of brain aging and offer hope for future treatments to preserve cognitive function. Identifying a single protein like FTL1 as a key driver of age-related memory loss simplifies the path toward potential interventions, complementing existing lifestyle-based approaches.

The details

The researchers found that as mice age, FTL1 levels naturally increase in the hippocampus, a brain region vital for memory. This elevation of FTL1 correlates with a decline in neural connections, disrupted energy production in neurons, and poorer memory performance. By artificially lowering FTL1 in aged mice, the team was able to reverse these cognitive impairments, restoring synaptic function, increasing neural connections, and improving the mice's memory to levels similar to much younger animals.

  • The study was published in August 2025.
  • The UCSF research team has been investigating the role of FTL1 in brain aging since the early 2020s.

The players

Saul Villeda

The lead researcher on the UCSF study, who emphasized the significance of the findings in rejuvenating the aging brain at a molecular level.

University of California, San Francisco (UCSF)

The research institution where the groundbreaking study on the role of FTL1 in cognitive decline was conducted.

Got photos? Submit your photos here. ›

What they’re saying

“Targeting FTL1 appeared to rejuvenate the brain at a molecular level.”

— Saul Villeda, Lead Researcher

“By artificially lowering FTL1 in aged mice, the researchers observed a remarkable reversal of cognitive impairments.”

— Saul Villeda, Lead Researcher

What’s next

The UCSF team plans to further investigate the exact mechanisms by which FTL1 contributes to cognitive decline, as well as explore the potential for developing safe, brain-penetrating drugs or gene therapies to modulate FTL1 levels in humans.

The takeaway

The UCSF discovery represents a significant breakthrough in the understanding of brain aging and opens up new avenues for developing targeted therapies to combat cognitive decline. While human applications remain years away, the study injects fresh hope into the quest for healthier cognitive aging, complementing existing lifestyle-based approaches.